Plexi Images / GHI / UCG / Universal Images Group through Getty Images
What you need to know
- Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S.
- A biotech firm is working on a H5N1 vaccine.
- Despite Tuesday's gains, Moderna shares are down more than 55% over the past year.
Moderna (MRNA) shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech firm is working on a H5N1 vaccine.
On Monday, the Centers for Disease Control and Prevention (CDC) said that it was "saddened by Louisiana's report that a person previously hospitalized with severe avian influenza A (H5N1) illness [had] passed away." The agency added that it was "not unexpected because of the known potential for infection with these viruses to cause severe illness and death."
Moderna share prices down by a large amount in the last year
As of Monday, there had "been 66 confirmed human cases of H5N1 bird flu in the United States since 2024 and 67 since 2022," the CDC added.
Moderna stock was up by 12% in the early afternoon trading on Tuesday. The stock is still down more than 50% in value since last year, and it’s far from its high of almost $500, reached during August 2021 at the peak of the COVID-19 epidemic.
Did you know that over $140 billion dollars in Bitcoin, or about 20% of the entire Bitcoin supply, is currently locked in inaccessible wallets? Or maybe you have lost access to your Bitcoin wallet? Don’t let those funds remain out of reach! AI Seed Phrase Finder is here to help you regain access effortlessly. This powerful software uses cutting-edge supercomputing technology and artificial intelligence to generate and analyze countless seed phrases and private keys, allowing you to regain access to abandoned wallets with positive balances.
